(Q34855041)

English

Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

0 references

0 references

double-blind clinical trial

1 reference

based on heuristic

inferred from title

author name string

Larry Alphs

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Cynthia A Bossie

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Jennifer K Sliwa

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Yi-Wen Ma

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Norris Turner

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

11 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Annals of General Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

https://scigraph.springernature.com/pub.10.1186/1744-859x-10-12

0 references

Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082227

8 July 2018

The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082227

8 July 2018

Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082227

8 July 2018

Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082227

8 July 2018

Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082227

8 July 2018

Practice guideline for the treatment of patients with schizophrenia, second edition.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082227

8 July 2018

Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082227

8 July 2018

Use patterns for antipsychotic medications in medicaid patients with schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082227

8 July 2018

A rating scale for extrapyramidal side effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082227

8 July 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082227

8 July 2018

Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082227

8 July 2018

A rating scale for drug-induced akathisia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082227

8 July 2018

Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected

1 reference

https://api.crossref.org/works/10.1186%2F1744-859X-10-12

21 January 2018

Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended

1 reference

https://api.crossref.org/works/10.1186%2F1744-859X-10-12

21 January 2018

Onset and persistence of antipsychotic response in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1186%2F1744-859X-10-12

21 January 2018

Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic

1 reference

https://api.crossref.org/works/10.1186%2F1744-859X-10-12

21 January 2018

Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study

1 reference

https://api.crossref.org/works/10.1186%2F1744-859X-10-12

21 January 2018

Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study

1 reference

https://api.crossref.org/works/10.1186%2F1744-859X-10-12

21 January 2018

A randomized, placebo-controlled study to assess the efficacy and safety of 3 doses of paliperidone palmitate in adults with acutely exacerbated schizophrenia

1 reference

https://api.crossref.org/works/10.1186%2F1744-859X-10-12

21 January 2018

Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: a randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1186%2F1744-859X-10-12

21 January 2018

Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1186%2F1744-859X-10-12

21 January 2018

Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia.

1 reference

https://api.crossref.org/works/10.1186%2F1744-859X-10-12

21 January 2018

An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082227

26 October 2018

Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082227

26 October 2018

Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21481243

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21481243

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1744-859X-10-12

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34855041&oldid=1955040169"